CRP |
An acute phase reactant that plays a fundamental role in natural host defense and innate immunity during renal injury |
Plasma CRP could be used as an indicator of early stages of diabetic nephropathy |
TNF-α |
Is involved in systemic inflammation via increasing the formation of lymphocyte chemoattractant factors and cell surface expression of intercellular adhesion molecule-1 which has been implicated in the development of diabetic nephropathy |
Urinary TNF-α levels could be used as a marker for the development and progression of diabetic nephropathy |
MCP-1 |
Mediates macrophage infiltration and accumulation in diabetic nephropathy |
Urinary MCP-1 levels is an important marker to detect the progression of later stages of diabetic nephropathy |
ICAM-1 |
Promotes leukocyte adhesion and is involved in renal infiltration of macrophages in diabetic nephropathy |
Urinary ICAM-1 could be used as an early marker for monitoring the progression of diabetic nephropathy |
TGF-β |
TGF-β plays an important role in the development of glomerulosclerosis and interstitial fibrosis in diabetes via enhancing glomerular extracellular matrix formation. |
Urinary TGF-β could be used as an early marker for the progression of diabetic nephropathy |
CCN2 |
CCN2 is the key factor in stimulating connective tissue cell proliferation, extracellular matrix production, and other profibrotic properties of TGF-β during diabetes |
1-Urinary CCN2 levels could be used as a marker of early stage of diabetic nephropathy |
2-Plasma CCN2 levels could be used as a marker for the late stage of diabetic nephropathy |